CN103920099A - Medicine composition for treating chronic cholecystitis - Google Patents
Medicine composition for treating chronic cholecystitis Download PDFInfo
- Publication number
- CN103920099A CN103920099A CN201410192486.3A CN201410192486A CN103920099A CN 103920099 A CN103920099 A CN 103920099A CN 201410192486 A CN201410192486 A CN 201410192486A CN 103920099 A CN103920099 A CN 103920099A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- fructus
- chronic cholecystitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to medicine composition for treating chronic cholecystitis. The medicine composition for treating the chronic cholecystitis comprises scutellaria baicalensis, safflowers, araliaceae acanthopanax trifoliatus, gardenia, artemisiacapillaris thunb, rheum officinale and the like. The medicine composition for treating the chronic cholecystitis is reasonable in composition method, and has the efficacies of liver harmonizing and bile benefiting, qi regulating and pain relieving, and spleen nvigorating and dampness eliminating, and achieves the purpose of treating the chronic cholecystitis.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of pharmaceutical composition for the treatment of chronic cholecystitis.
Background technology
Chronic cholecystitis is a kind of comparatively common chronic inflammation gallbladder disease clinically.Primary disease is many to be infected and is caused the delay that repeatedly shows effect of acute cholecystitis disease by cholestasis, antibacterial.Use clinically in recent years Chinese medicine bringing into play more and more important effect aspect treatment chronic cholecystitis.
Summary of the invention
The object of this invention is to provide a kind of pharmaceutical composition for the treatment of chronic cholecystitis.
In order to realize object of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of chronic cholecystitis, the crude drug that it comprises following weight portion: Radix Scutellariae 10-30 part, Flos Carthami 1-20 part, Radix Acanthopanacis Trifoliati 10-30 part, Fructus Gardeniae 10-20 part, Herba Artemisiae Scopariae 10-30 part, Radix Et Rhizoma Rhei 1-30 part, Radix Curcumae 1-20 part, Rhizoma Polygoni Cuspidati 10-30 part, Fructus Pistaciae Verae 10-20 part, Fructus Aurantii 1-25 part, Caulis Sargentodoxae 10-35 part, Radix Glycyrrhizae 1-15 part, Dendronenthamia japonica var.chinensis 10-20 part, Herba Lysimachiae 1-15 part, Semen Persicae 10-30 part and Resina Ferulae 10-20 part.
Preferably, the crude drug that the pharmaceutical composition of described treatment chronic cholecystitis comprises following weight portion: 12 parts of 15 parts of Radix Scutellariaes, 9 parts, Flos Carthami, 15 parts of Radix Acanthopanacis Trifoliatis, 17 parts of Fructus Gardeniaes, 11 parts of Herba Artemisiae Scopariaes, 6 parts of Radix Et Rhizoma Rhei, 8 parts of Radix Curcumaes, 15 parts of Rhizoma Polygoni Cuspidati, 12 parts of Fructus Pistaciae Veraies, 10 parts of Fructus Aurantiis, 25 parts of Caulis Sargentodoxae, 12 parts, Radix Glycyrrhizae, 15 parts of Dendronenthamia japonica var.chinensis, 8 parts of Herba Lysimachiaes, 12 parts, Semen Persicae and Resina Ferulaes.
Preferably, the pharmaceutical composition of described treatment chronic cholecystitis also comprises the crude drug of following weight portion: Rhizoma Chuanxiong 10-20 part, Shuteria pampaniniana Hand.-Mazz. 1-30 part, Ramulus Cinnamomi 10-30 part, Herba Pellioniae repentis 1-20 part, Radix Paeoniae Alba 10-30 part, Semen Ciceris Arietini 10-30 part, Radix Codonopsis 10-30 part, Rhizoma Zingiberis 10-20 part, Herba Astragali Sinici 10-30 part, Fructus Rosae Laevigatae 1-20 part, Taxillus caloreas (Diels) Danser 1-30 part, Herba Sedi 1-20 part, Fructus Lycii 10-30 part, Herba Lysimachiae Grammicae 10-30 part and Semen Sesami Nigrum 1-20 part.
Preferably, the pharmaceutical composition of described treatment chronic cholecystitis also comprises the crude drug of following weight portion: 10 parts of 15 parts of Rhizoma Chuanxiongs, 10 parts of Shuteria pampaniniana Hand.-Mazz.s, 20 parts of Ramulus Cinnamomi, 8 parts of Herba Pellioniae repentiss, 12 parts of the Radix Paeoniae Albas, 20 parts of Semen Ciceris Arietinis, 15 parts of Radix Codonopsis, 12 parts of Rhizoma Zingiberiss, 20 parts of Herba Astragali Sinici, 9 parts of Fructus Rosae Laevigatae, 10 parts of Taxillus caloreas (Diels) Danser, 8 parts of Herba Sedis, 15 parts of Fructus Lycii, 20 parts of Herba Lysimachiae Grammicaes and Semen Sesami Nigrums.
More preferably, described pharmaceutical composition can be tablet, dispersible tablet, disintegrating tablet, instant, enteric coatel tablets, capsule or decoction.
In the present invention:
Radix Acanthopanacis Trifoliati is root or the root bark of Araliaceae Bai le.
Dendronenthamia japonica var.chinensis is the leaf of Cornaceae Dendrobenthamia Dendronenthamia japonica var.chinensis.
Herba Pellioniae repentis is the herb of Urticaceae Herba Pellioniae platymiscium Herba Pellioniae repentis.
Herba Astragali Sinici is the herb of leguminous plant Herba Astragali Melilotoidis (Herba Astragali Sinici).
Herba Lysimachiae Grammicae is the herb of Ofthe Primulaceae Herba Lysimachiae Grammicae.
Shuteria pampaniniana Hand.-Mazz. is the herb of leguminous plant hair place bud bean.
In compositions of the present invention, Herba Pellioniae repentis, Shuteria pampaniniana Hand.-Mazz. and Herba Lysimachiae Grammicae are monarch drug; Radix Scutellariae, Flos Carthami, Fructus Gardeniae, Herba Artemisiae Scopariae, Radix Et Rhizoma Rhei, Fructus Aurantii, Radix Glycyrrhizae, Semen Persicae, Rhizoma Polygoni Cuspidati, the Radix Paeoniae Alba, Ramulus Cinnamomi are ministerial drug; Radix Acanthopanacis Trifoliati, Radix Curcumae, Fructus Pistaciae Verae, Herba Astragali Sinici, Semen Ciceris Arietini, Herba Sedi, Fructus Lycii, Resina Ferulae, Fructus Rosae Laevigatae, Herba Lysimachiae, Caulis Sargentodoxae, Dendronenthamia japonica var.chinensis, Radix Codonopsis are adjuvant drug; Rhizoma Chuanxiong, Rhizoma Zingiberis, Taxillus caloreas (Diels) Danser and Semen Sesami Nigrum are for making medicine.The reasonable recipe of the pharmaceutical composition for the treatment of chronic cholecystitis of the present invention, for thering is the liver of tune function of gallbladder promoting, regulating QI to relieve pain, invigorating the spleen to clear away damp pathogen effect, thus reach the object for the treatment of chronic cholecystitis.
Detailed description of the invention
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for the present invention instead of limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment decoction of the present invention
Get 15 grams of Radix Scutellariaes, 9 grams, Flos Carthami, 15 grams of Radix Acanthopanacis Trifoliatis, 17 grams of Fructus Gardeniaes, 11 grams of Herba Artemisiae Scopariaes, 6 grams of Radix Et Rhizoma Rhei, 8 grams of Radix Curcumaes, 15 grams of Rhizoma Polygoni Cuspidati, 12 grams of Fructus Pistaciae Veraies, 10 grams of Fructus Aurantiis, 25 grams of Caulis Sargentodoxae, 12 grams, Radix Glycyrrhizae, 15 grams of Dendronenthamia japonica var.chinensis, 8 grams of Herba Lysimachiaes, 12 grams, Semen Persicae, 12 grams of Resina Ferulaes, 15 grams of Rhizoma Chuanxiongs, 10 grams of Shuteria pampaniniana Hand.-Mazz.s, 20 grams of Ramulus Cinnamomi, 8 grams of Herba Pellioniae repentiss, 12 grams of the Radix Paeoniae Albas, 20 grams of Semen Ciceris Arietinis, 15 grams of Radix Codonopsis, 12 grams of Rhizoma Zingiberiss, 20 grams of Herba Astragali Sinici, 9 grams of Fructus Rosae Laevigatae, 10 grams of Taxillus caloreas (Diels) Danser, 8 grams of Herba Sedis, 15 grams of Fructus Lycii, 10 grams of 20 grams of Herba Lysimachiae Grammicaes and Semen Sesami Nigrums, add 2000 milliliters, water, in the flask that condenser is housed, at 100 DEG C, heat 6 hours, filter, filtrate is decoction of the present invention.
Experimental example
Clinical data
The diagnostic criteria of chronic cholecystitis in reference " practical internal medicine " (Chen Haozhu. practical internal medicine [M] .7 version. Beijing: People's Health Publisher, 2005:2043-2046) make a definite diagnosis chronic cholecystitis patient 30 examples, wherein male 18 examples, female's 12 examples, the oldest person 62 years old, reckling 49 years old; Simple cholecystitis person 17 examples, merge cholelithiasis person's 8 examples, postcholecystectomy 5 examples.
The decoction making in oral embodiment is treated, and one day twice, each oral 100 milliliters, treats continuously 10 days.
Criterion of therapeutical effect
Effective: symptom disappears completely.Without right rib pain and malaise symptoms, be radiated to back symptom without pain, without upper abdominal pain, heating installation, have the hiccups, the indigestion symptom such as anorexia greasy food, poor appetite; Effective: symptom is obviously alleviated, occasionally have right rib pain and malaise symptoms, substantially without upper abdominal pain, air-breathing, have the hiccups, the indigestion symptom such as anorexia greasy food, poor appetite; Invalid: symptom is not improved.
Result
Through treatment, find effective 21 examples, effective 8 examples, invalid 1 example, total effective rate is 96.7%.
Claims (5)
1. treat the pharmaceutical composition of chronic cholecystitis for one kind, it is characterized in that the crude drug that it comprises following weight portion: Radix Scutellariae 10-30 part, Flos Carthami 1-20 part, Radix Acanthopanacis Trifoliati 10-30 part, Fructus Gardeniae 10-20 part, Herba Artemisiae Scopariae 10-30 part, Radix Et Rhizoma Rhei 1-30 part, Radix Curcumae 1-20 part, Rhizoma Polygoni Cuspidati 10-30 part, Fructus Pistaciae Verae 10-20 part, Fructus Aurantii 1-25 part, Caulis Sargentodoxae 10-35 part, Radix Glycyrrhizae 1-15 part, Dendronenthamia japonica var.chinensis 10-20 part, Herba Lysimachiae 1-15 part, Semen Persicae 10-30 part and Resina Ferulae 10-20 part.
2. the pharmaceutical composition for the treatment of chronic cholecystitis according to claim 1, it is characterized in that the crude drug that it comprises following weight portion: 12 parts of 15 parts of Radix Scutellariaes, 9 parts, Flos Carthami, 15 parts of Radix Acanthopanacis Trifoliatis, 17 parts of Fructus Gardeniaes, 11 parts of Herba Artemisiae Scopariaes, 6 parts of Radix Et Rhizoma Rhei, 8 parts of Radix Curcumaes, 15 parts of Rhizoma Polygoni Cuspidati, 12 parts of Fructus Pistaciae Veraies, 10 parts of Fructus Aurantiis, 25 parts of Caulis Sargentodoxae, 12 parts, Radix Glycyrrhizae, 15 parts of Dendronenthamia japonica var.chinensis, 8 parts of Herba Lysimachiaes, 12 parts, Semen Persicae and Resina Ferulaes.
3. the pharmaceutical composition for the treatment of chronic cholecystitis according to claim 2, it is characterized in that, it also comprises the crude drug of following weight portion: Rhizoma Chuanxiong 10-20 part, Shuteria pampaniniana Hand.-Mazz. 1-30 part, Ramulus Cinnamomi 10-30 part, Herba Pellioniae repentis 1-20 part, Radix Paeoniae Alba 10-30 part, Semen Ciceris Arietini 10-30 part, Radix Codonopsis 10-30 part, Rhizoma Zingiberis 10-20 part, Herba Astragali Sinici 10-30 part, Fructus Rosae Laevigatae 1-20 part, Taxillus caloreas (Diels) Danser 1-30 part, Herba Sedi 1-20 part, Fructus Lycii 10-30 part, Herba Lysimachiae Grammicae 10-30 part and Semen Sesami Nigrum 1-20 part.
4. the pharmaceutical composition for the treatment of chronic cholecystitis according to claim 3, it is characterized in that, it also comprises the crude drug of following weight portion: 10 parts of 15 parts of Rhizoma Chuanxiongs, 10 parts of Shuteria pampaniniana Hand.-Mazz.s, 20 parts of Ramulus Cinnamomi, 8 parts of Herba Pellioniae repentiss, 12 parts of the Radix Paeoniae Albas, 20 parts of Semen Ciceris Arietinis, 15 parts of Radix Codonopsis, 12 parts of Rhizoma Zingiberiss, 20 parts of Herba Astragali Sinici, 9 parts of Fructus Rosae Laevigatae, 10 parts of Taxillus caloreas (Diels) Danser, 8 parts of Herba Sedis, 15 parts of Fructus Lycii, 20 parts of Herba Lysimachiae Grammicaes and Semen Sesami Nigrums.
5. according to the pharmaceutical composition of the treatment chronic cholecystitis described in any one in claim 1 to 4, it is characterized in that, described pharmaceutical composition can be tablet, dispersible tablet, disintegrating tablet, instant, enteric coatel tablets, capsule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410192486.3A CN103920099A (en) | 2014-05-08 | 2014-05-08 | Medicine composition for treating chronic cholecystitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410192486.3A CN103920099A (en) | 2014-05-08 | 2014-05-08 | Medicine composition for treating chronic cholecystitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103920099A true CN103920099A (en) | 2014-07-16 |
Family
ID=51138641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410192486.3A Pending CN103920099A (en) | 2014-05-08 | 2014-05-08 | Medicine composition for treating chronic cholecystitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103920099A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362833A (en) * | 2015-12-15 | 2016-03-02 | 钟柏根 | Medicine composition for treating chronic cholecystitis and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102973890A (en) * | 2012-12-04 | 2013-03-20 | 宁夏易欣回药科技有限公司 | Traditional Chinese medicine composition for treating cholecystitis gall-stone |
| CN103432238A (en) * | 2013-08-26 | 2013-12-11 | 天津开发区经经新优技术产品开发有限公司 | Traditional Chinese medicine decoction for treating abdominal pain due to Qi stagnancy and blood stasis by one dose each day |
-
2014
- 2014-05-08 CN CN201410192486.3A patent/CN103920099A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102973890A (en) * | 2012-12-04 | 2013-03-20 | 宁夏易欣回药科技有限公司 | Traditional Chinese medicine composition for treating cholecystitis gall-stone |
| CN103432238A (en) * | 2013-08-26 | 2013-12-11 | 天津开发区经经新优技术产品开发有限公司 | Traditional Chinese medicine decoction for treating abdominal pain due to Qi stagnancy and blood stasis by one dose each day |
Non-Patent Citations (2)
| Title |
|---|
| 王小平: "桂萸芍甘汤治疗胆囊炎并胆结石47例", 《陕西中医》 * |
| 郑琳: "清热利湿活血法治疗慢性胆囊炎186例", 《中国社区医师》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362833A (en) * | 2015-12-15 | 2016-03-02 | 钟柏根 | Medicine composition for treating chronic cholecystitis and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN104399039A (en) | Medicament for treating ulcerative colitis and preparation method thereof | |
| CN101757534A (en) | Traditional Chinese medicine for treating chronic dysentery | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN103100035B (en) | Traditional Chinese medicine (TCM) decoction for treating globus hysteriocus | |
| CN104173727A (en) | Medicine for treating toothache | |
| CN103920099A (en) | Medicine composition for treating chronic cholecystitis | |
| CN106511584A (en) | Drug for treating postpartum fever | |
| CN104840927A (en) | Traditional Chinese medicine for treating chronic erosive gastritis | |
| CN105641419A (en) | Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer | |
| CN105055657A (en) | Spraying agent for improving pain caused by wisdom teeth and preparation method thereof | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN103933470A (en) | Traditional Chinese medicine for treating gastric ulcer | |
| CN104623578A (en) | Traditional Chinese medicine composition for treating chronic enteritis | |
| CN105770628A (en) | Traditional Chinese medicine for treating psoriasis | |
| CN102205087B (en) | Chinese medicinal composition for treating chronic gastritis and preparation method thereof | |
| CN102949684B (en) | Medicine formula for treating rheumatoid arthritis | |
| CN101176768A (en) | Epityphlon health | |
| CN104547246A (en) | Traditional Chinese medicine composition for treating haemorrhoids | |
| CN105327157A (en) | Traditional Chinese medicine for treating cerebrovascular blockage and preparation method thereof | |
| CN104800599A (en) | Traditional Chinese medicinal composition for treating deficiency of kidney-yin | |
| CN105617225A (en) | Traditional Chinese medicine for treating lymphoma | |
| CN104758455A (en) | Traditional Chinese medicine composition for treating chronic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140716 |